Abiraterone in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and MDV3100.
暂无分享,去创建一个
B. Escudier | Y. Loriot | M. Palma | K. Fizazi | P. Blanchard | C. Massard | A. Bossi | L. Albiges | M. di Palma | E. Ileana | A. Blesius